Randomized controlled trials for the efficacy between famotidine alone and combination of famotidine and egualen sodium hydrate on gastric ulcer healing for following eradication therapy for Helicobactor pylori
Not Applicable
- Conditions
- Gastric ulcer for following eradication therapy for Helicobactor pylori
- Registration Number
- JPRN-UMIN000007010
- Lead Sponsor
- Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with drug allegy 2.Patient taking Atananavir sulfate,Pimozide and Ergatamine-containing drugs 3.Patient who has been mononucleosis 4.Patients with severe liver and renal dysfunction, and serious heart-lung complication. 5.Pregnant, females who suckles, or females who wish to become pregnant 6.Patients who have eradication therapy of Helicobactor pylori infection 7.Patient who take PPI or H2RA within 1 month before obtaining informed consent 8.Patients who take mucosal protective medicine within 2 weeks before obtaining informed consent 9.Others,patients who are judged to be inadequate to participate in this trial by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The healing rate of gastric ulcer within 8 weeks
- Secondary Outcome Measures
Name Time Method The healing rate of gastric ulcer after 8 weeks QOL score (GSRS) after 2 weeks and 8 weeks